Erika Check Hayden is an award-winning, San Francisco-based science and technology reporter. She writes for Nature, and on a freelance basis for a variety of publications, and is a lecturer in the University of California, Santa Cruz Science Communication Program.
Erika Check Hayden
Freelance writer
From this contributor
For studies, size matters: Let us count the ways
In autism research, as in other fields, small sample sizes can lead to false findings. The size of the sample needed for statistical significance depends on the type of study.
For studies, size matters: Let us count the ways
By
Erika Check Hayden
17 October 2018 | 6 min read
Preprint server bioRxiv gets boost from Facebook billionaire
The Chan Zuckerberg Initiative has pledged to provide financial support for bioRxiv, a website where researchers can share manuscripts before peer review.
Preprint server bioRxiv gets boost from Facebook billionaire
By
Erika Check Hayden
28 April 2017 | 5 min read
Book review: ‘Rigor Mortis’ reveals rampant sloppiness in science
In his new book, journalist Richard Harris writes that lack of reproducibility in research poses a serious threat to science.
Book review: ‘Rigor Mortis’ reveals rampant sloppiness in science
By
Erika Check Hayden
4 April 2017 | 5 min read
Rising star: Somer Bishop fine-tunes autism diagnosis
Somer Bishop is launching a revolution in autism diagnosis, creating faster, more precise tools that speed research and better capture the full spectrum of autism symptoms.
Rising star: Somer Bishop fine-tunes autism diagnosis
By
Erika Check Hayden
28 April 2016 | 8 min read
Explore more from The Transmitter
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
By
Katie Moisse
15 December 2025 | 7 min read
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
How basic neuroscience has paved the path to new drugs
A growing list of medications—such as zuranolone for postpartum depression, suzetrigine for pain, and the gepants class of migraine medicines—exist because of insights from basic research.
By
Alex Kwan
15 December 2025 | 6 min read
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
Dispute erupts over universal cortical brain-wave claim
The debate highlights opposing views on how the cortex transmits information.
By
Claudia López Lloreda
12 December 2025 | 5 min read